ADME Toxicology Testing Market
According to Intent Market Research, the ADME Toxicology Testing Market is expected to grow from USD 5.5 billion in 2023 at a CAGR of 8.7% to touch USD 9.8 billion by 2030. The ADME Toxicology Testing Market is dominated by key players such as, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Yposkesi, Inc., Creative Biogene, and Pfizer Inc.